BTC is up 1.5% since the Iran conflict began, outperforming other major assets over the same period. Read more here.
Replimune (REPL) stock plunges as the company seeks layoffs following the FDA rejection of its cancer drug RP1 for melanoma.
Court of King’s Bench Justice puts legal pause on the certification until she makes a ruling on the case brought forward by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results